Figure S2 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy

Expression of SALL4-TCR in Jurkat TCR KO CD8+ T cells via mRNA electroporation. Representative FACS SALL4-teramer staining on Jurkat TCR KO CD8+ T cells electroporated with mRNA encoding α and β subunits for the SALL4-TCR (right) or an irrelevant-TCR (middle). Mock electroporated cells (no mRNA, left) were used for negative control.